IDK has recruited Pusha T for his Kaytranada-produced new song "LiFE 4 A LiFE," from his upcoming mixtape E.T.D.S - Even the ...

The adaptation of the beloved friends-to-lovers bestseller, People We Meet on Vacation, has arrived on Netflix, bringing ...

Dec. 24 (UPI) --Christmas music often brings to mind familiar carols and pop standards that return every December. But over the years, artists across punk, indie, hip-hop and alternative rock have ...

Cosmo Jiang, Partner at Pantera Capital, discusses the macroeconomic factors and industry-specific issues affecting near-term sentiment in the cryptocurrency market. He notes that token performance ...

Good morning. There was quite the split screen in the Oval Office on Monday. President Trump signed an executive order classifying fentanyl as a “weapon of mass destruction.” The exact implications of ...

In this episode of Electrified, Dylan Lumis breaks down a newly published Tesla patent that’s fueling speculation about Starlink integration and the upcoming Cybercab. He explains why the patent is ...

Axiom Space and Spacebilt plan to install an optically interconnected orbital data center node on the International Space Station in 2027. Credit: Axiom Space As the space industry explores orbital ...

Beyond Meat stock rocketed 36.5% higher in today's trading. There does not appear to be any major business-specific news behind the rally. Beyond Meat is facing a lot of long-term challenges, but the ...

Leading Indonesian music publisher Massive Music has begun development on an AI powered data-driven technology solution that could assist audiovisual producers in their creative process by more ...

October's meme-stock-driven rally seemed to renew interest in the beleaguered burger maker. Since Beyond Meat stock hit a 52-week high of $7.69 on Oct. 22, the shares have cratered 89%, as of this ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.71. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...

Paulo Artaxo does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond their ...